DoctoRx Unscripted – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

DoctoRx Unscripted

Bristol Myers Squibb

Science

Frequency: 1 episode/38d. Total Eps: 14

Welcome to DoctoRx Unscripted — where doctors shaping the next chapter of patient care come together for raw, real, and rigorously scientific conversations at the heart of medicine. Hosted by Dr. Tania Small, SVP of Global Medical Affairs — a physician who has dedicated her career to turning breakthrough science into real-world patient impact. In each episode, Dr. Small sits down with the world’s leading minds in medicine to dive into the breakthroughs, surface the unspoken realities, and tackle the real-world challenges shaping tomorrow’s standard of care.

No soundbites. No scripts.

Just evidence-based, peer-to-peer conversations that challenge thinking, ignite innovation, and equip you with insights to transform your own practice. So whether you’re in the clinic, the lab, or the boardroom — join us to rewrite patient care.

Unscripted. Unfiltered. Unapologetic.

Read moreCollapse

Site

RSS

Apple

Data updated on 31/10/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

No links shared by this podcast

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 58%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Beyond the Tumor: From Evidence to Action – Part 2

Episode 10

Tuesday, September 22, 2026 • Duration 26:52

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for Part 2 of this DoctoRx Unscripted conversation exploring how biology-based behavior change is redefining cancer care. In Part 2, Dr. Small hosts Arianna Huffington, Founder and CEO of Thrive Global, and Chris Boerner, Board Chair and CEO of Bristol Myers Squibb, for a candid discussion on moving beyond treating the tumor to delivering true whole-person care. Together, they explore:

How everyday factors, like sleep, stress, movement, and social connection, impact cancer care
Simple steps to reinforce healthier daily routines
Why lifestyle changes remain critical alongside medical therapies
How pharma leaders can integrate behavioral metrics into clinical trials
Strategies to overcome healthcare disparities and expand access to behavioral health tools

Medicines and healthy behaviors achieve more together than either can alone. Tune in to see why placing the patient at the center of oncology care can drive better long-term outcomes.

Read moreCollapse

Beyond the Tumor: From Biology to Behavior – Part 1

Episode 9

Tuesday, September 22, 2026 • Duration 53:27

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for Part 1 of a timely DoctoRx Unscripted conversation with Dr. Neil Iyengar, board-certified medical oncologist and Director of Survivorship Services at Winship Cancer Institute of Emory University. Together, they examine how metabolism, body composition, the gut microbiome, stress, and sleep influence cancer risk, treatment response, and long-term survivorship. In this episode, Dr. Small and Dr. Iyengar discuss:

Why muscle-to-fat ratio matters more than BMI for health and cancer risk
The connection between gut health, fiber, and cancer treatment success
What new research reveals about GLP-1s in oncology
How clinicians can make tailored exercise and nutrition accessible to every patient

Learn how targeted lifestyle interventions pair with precision oncology.

Read moreCollapse

Lung Cancer – No Longer the Disease We Once Thought It Was

Episode 8

Wednesday, May 20, 2026 • Duration 44:32

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a forward-looking episode of DoctoRx Unscripted, featuring leading thoracic oncologists Dr. Christine Lovly and Dr. Nate Pennell. Together, they examine innovations redefining what’s possible for patients with lung cancer:

Biomarker-driven therapy and molecular profiling;
Liquid biopsy and ctDNA testing;
AI-assisted detection and radiomics; and
Next-generation immunotherapies, including bispecifics, T-cell engagers, and personalized vaccines.

They also share their perspectives on a critical challenge: translating scientific progress into real-world impact by expanding access and closing gaps in care. If you're working to advance oncology care—or interested in deepening your understanding of what’s shaping its future—this is a conversation you don’t want to miss.

Read moreCollapse

Part 3 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight

Episode 7

Wednesday, February 25, 2026 • Duration 38:11

Part 3 - The Movement

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 3, Dr. Small sits down with patient advocate Lisa Salberg, founder of the Hypertrophic Cardiomyopathy Association (HCMA), to explore how a personal diagnosis evolved into a global movement—helping to establish more than 60 Centers of Excellence around the world.

The conversation reinforces why embedding the patient voice early is essential to advancing cardiovascular medicine.

Read moreCollapse

Part 2 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight

Episode 7

Wednesday, February 25, 2026 • Duration 53:04

Part 2 - The Shift

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 2, Dr. Small welcomes HCM expert Dr. Matthew Martinez and leading cardiologist Dr. Nani Bhalla. Together, they examine why HCM has historically been so difficult to detect—and what has changed in recent years to begin altering that trajectory.

The discussion explores how earlier recognition, paired with more precise and individualized treatment decisions, can change outcomes in meaningful and lasting ways.

Read moreCollapse

Part 1 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight

Episode 7

Wednesday, February 25, 2026 • Duration 26:00

Part 1 - The Moment

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 1, NFL tight end Tommy Sweeney shares his experience being diagnosed with HCM. He reflects on his personal journey— from diagnosis and treatment decision making to his return to the NFL with his condition appropriately treated and well managed. His story underscores a sobering reality: HCM can remain undetected even in individuals who receive frequent medical screenings, like elite athletes.

Read moreCollapse

Part 2 - Myeloma: The New Playbook

Episode 6

Wednesday, December 3, 2025 • Duration 35:45

Highlights include: • Early detection and the potential of screening studies like PROMISE and iStopMM • Modifiable risk factors—how diet, exercise, and inflammation shape disease and outcomes • Emerging therapies on the horizon • Why “down with dex” and other old beliefs deserve retirement • The personal “why” behind every advance in myeloma care

About the Experts

Dr. Paul Richardson

Dr. Paul Richardson is an internationally recognized visionary in hematology and oncology whose trailblazing research at Dana-Farber Cancer Institute and Harvard Medical School has driven therapeutic revolutions in multiple myeloma, transforming patient outcomes and defining today’s standards of care. In addition to his involvement in the approval of nearly every major therapy for the disease over the past two decades, he is also one of the most prolific and cited experts in the field, with nearly 500 original articles and 400 reviews.

Dr. Richardson is a paid consultant for BMS.

Dr. Joseph Mikhael Dr. Joseph Mikhael has revolutionized and broadened access to world-class myeloma care globally through his pioneering leadership at TGen and the International Myeloma Foundation and as principal investigator of numerous groundbreaking clinical trials, setting new benchmarks in innovation, impact, and equity. Celebrated as a dynamic champion for underserved communities, an award-winning educator, and a masterful communicator, Dr. Mikhael has authored over 150 influential scientific articles and was recently recognized among America’s Top 100 Doctors for his transformational contributions to the field.

Dr. Mikhael was not compensated for his participation.

Dr. Mecide Gharibo

Dr. Mecide Gharibo is an innovative hematology leader whose passion for transforming patient care extends from academic clinical expertise at Rutgers Cancer Institute to launching breakthrough therapies as Global Head of Hematology at Bristol Myers Squibb. Renowned for advancing life-saving treatments and optimizing patient access, Dr. Gharibo’s clinical excellence and senior pharmaceutical leadership have fueled medical innovation and set new standards for care through a proven record of successful therapy approvals.

Part 1 - Myeloma: The New Playbook

Episode 6

Wednesday, December 3, 2025 • Duration 53:52

Highlights include: • How MRD is reshaping drug development and accelerating innovation • The evolution of next-generation and targeted therapies with the goal of achieving deeper and more durable remissions • New thinking on “hit hard early” vs “save the best for last” treatment strategies • The impact of race, biology, and access on outcomes—and what’s changing that trajectory

If you want to understand the science, urgency, and humanity driving today’s breakthroughs, this episode is your front-row seat to the bleeding edge of discovery.

About the Experts

Dr. Paul Richardson

Dr. Richardson is a paid consultant for BMS.

Dr. Mikhael was not compensated for his participation.

Dr. Mecide Gharibo

Colorectal Cancer: The Hidden Drivers

Episode 5

Thursday, October 16, 2025 • Duration 57:47

Dr. Tania Small sits down with Dr. Heinz-Josef Lenz, one of the world’s greatest minds in gastrointestinal medical research, for a thought-provoking conversation on the future of colorectal cancer (CRC) care.

Together, they unpack the rising incidence of early-onset CRC and the factors driving the surge of new cases in younger patients. This conversation dives into cutting-edge innovations that are reshaping detection and treatment:

ctDNA liquid biopsies and minimal residual disease testing - revolutionizing how relapse is detected.
Next-generation diagnostics and precision screening, including AI-assisted colonoscopies - enabling earlier, more accurate identification.
Methylation profiling, tumor microenvironment and epigenetic therapies - advancing personalized therapy and novel treatments.
Immunotherapies and targeted agents - moving to the “front line” with the potential to transform treatment approaches into organ-preserving strategies.

But the conversation doesn’t stop at science. Together, they examine the influence of lifestyle, disparities in access, and patient-driven data on survival.

If you're driving change in oncology, this episode offers practical insights on integrating molecular testing, rethinking prevention, and preparing for the innovations ahead.

About Dr Heinz-Josef Lenz

Heinz-Josef Lenz, MD, is an award-winning trailblazer and mentor whose pioneering work in colorectal cancer gene regulation, drug resistance, early detection and surveillance has reshaped the field of oncology. He is the recipient of multiple prestigious honors, including the ASCO Young Investigator Award, Career Development Award and the USC Mentoring Award, celebrating his excellence in both research and mentorship. Dr Lenz also serves on national committees including SWOG, NCI Task Forces and advisory boards and has authored numerous peer-reviewed publications.

Dr Lenz is a professor of medicine, Preventive Medicine and Cancer Biology J Terrence Lanni chair in Cancer Research. He is also deputy Cancer Center director at USC Norris and co-director of USC Brown Center for Cancer Drug Development.

Cancer. Detected. Disrupted. Defied: 2025 ASCO® Annual Meeting

Episode 4

Wednesday, August 6, 2025 • Duration 54:31

In this special edition of DoctoRx Unscripted, Dr. Tania Small sits down with three of the most visionary leaders in oncology, Dr. Lillian Siu, Dr. Fabrice André and Dr. Howard “Skip” Burris for a provocative conversation on data that has the potential to redefine the future of cancer care. They unpack cutting-edge findings—from next-generation diagnostics and novel modalities to AI-powered trials, precision medicine, prevention and what’s coming next in oncology innovation. But the conversation goes beyond the data and tackles the decisions, behaviors and systems needed to shape real-world outcomes. They explore how lifestyle modifications may enhance treatment, efficacy and survival, and what it will take to improve global access to optimal cancer care and provide lasting impact through patient-driven science and purposeful action.

This unforgettable episode spotlights the potential breakthroughs poised to detect cancer earlier and challenge conventional paradigms, with the goal of delivering better outcomes for patients worldwide. If you're a clinician, researcher, or advocate at the forefront of oncology, this is your front-row seat to the future told by the pioneers shaping it. Dr. André, Dr. Burris and Dr. Siu are paid consultants for BMS.

Read moreCollapse

DoctoRx Unscripted – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

DoctoRx Unscripted – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities